Health company blames Sarbox for delisting
Biopharmaceutical company says compliance to much of a burden
The company, is also listed on the LSE, a listing it said would protect
Vernalis is set to file its application to delist from the tech-heavy index
by the end of next week and the delisting will come into effect ten days later.
It has decided to delist despite a ‘buy’ signal from broker Goldman Sachs.